Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis
Suetonia C. Palmer(University of Otago), Giovanni FM Strippoli(The University of Sydney), Eliano Pio Navarese(Nicolaus Copernicus University), Marcello Tonelli(University of Calgary), Jonathan C. Craig(Flinders University), Dimitris Mavridis(Délégation Paris 5), Georgia Salanti(University of Bern), Marinella Ruospo(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), David C. Wheeler(Roland Hill (United Kingdom)), Natasha Wiebe(University of Alberta)
Cited by 394
Related Papers
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
|Annals of Internal Medicine|2015|8.2k
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
|Journal of Clinical Epidemiology|2010|3.8k
Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis
|The Lancet|2018|3.5k
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
|The Lancet|2013|2.5k
Graphical Tools for Network Meta-Analysis in STATA
|PLoS ONE|2013|2.5k